Pharmaceutical packaging engineers design and develop packaging systems that ensure the safety, stability, and integrity of pharmaceutical products from production through delivery to patients. Their work involves selecting materials and packaging configurations that protect drugs from environmental factors like moisture, light, oxygen, and microbial contamination, which can degrade product quality. They also incorporate critical features such as tamper-evident seals, child-resistant closures, and clear labeling to enhance patient safety and regulatory compliance. By ensuring proper packaging, these engineers help maintain the efficacy and shelf life of medications, contributing directly to public health outcomes.
Pharmaceutical packaging engineers conduct rigorous testing to assess mechanical strength, barrier properties, and compatibility with drug formulations. They collaborate closely with formulation scientists, quality assurance teams, and regulatory agencies to ensure packaging meets global standards and facilitates efficient manufacturing and distribution processes. Increasingly, they focus on sustainability initiatives by developing eco-friendly packaging materials and reducing waste without compromising safety. Pharmaceutical packaging engineers play a vital role in bridging pharmaceutical development and patient delivery, ensuring medications are both safe and accessible worldwide. Their innovations continue to drive advancements in packaging technology, enhancing both product protection and patient experience. Their work also supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico